» Articles » PMID: 28293320

STNF-R Levels: Apical Periodontitis Linked to Coronary Heart Disease

Overview
Specialty General Medicine
Date 2017 Mar 16
PMID 28293320
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Different studies have implicated the exposure to systemic conditions in the aetiology of cardiovascular diseases like chronic inflammation including chronic periodontitis.

Aim: The present study has been conducted to examine whether biomarker sTNF-R was elevated in apical periodontitis as sTNF-R is a systemic marker of inflammation and has been identified as risk factors for cardiovascular diseases.

Material And Methods: sTNF-R levels were measured in 52 patients with apical periodontitis (M:F::25:27), aged 20-45 years and in 20 control patients without periodontitis (M:F::10:10, aged 20-48 years). Measurement of sTNF-R1 and sTNF-R2 was carried out in duplicate with standardised, commercially available enzyme immunoassays (R&D Systems Europe, Abingdon, UK).

Results: The mean sTNF-R1 and sTNF-R2 levels in periodontitis were 820 (240) pg/ml (413 - 1620 pg/ml) and 1309 (403) pg/ml (540 - 2430 pg/ml), while in normal sTNF-R1 and sTNF - R2 levels were 740 (340) pg/ml (407-1240 pg/ml) and 1283 (414) pg (480 - 2340 pg/ml) respectively. Results indicated a positive high relationship between cardiovascular markers such as sTNF-R1 and sTNF - R2 and apical periodontitis.

Conclusion: Elevated levels of sTNF-R1 and sTNF - R2 in apical periodontitis patients indicate an increased independent risk of coronary heart disease.

Citing Articles

Prevalence of Apical Periodontitis in patients with Multiple Myeloma.

Onate-Sanchez R, Perez-Diaz S, Rodriguez-Lozano F, Guerrero-Girones J Med Oral Patol Oral Cir Bucal. 2020; 25(3):e383-e387.

PMID: 32134898 PMC: 7211371. DOI: 10.4317/medoral.23416.


Retraction: Singhal R, Rai B. sTNF-R Levels: Apical Periodontitis Linked to Coronary Heart Disease. Open Access Maced J Med Sci. 2017; 5(1):68-1.

Spiroski M Open Access Maced J Med Sci. 2019; 7(10):1691.

PMID: 31231433 PMC: 6560296. DOI: 10.3889/oamjms.2019.225.

References
1.
Wilson P, DAgostino R, Levy D, Belanger A, Silbershatz H, Kannel W . Prediction of coronary heart disease using risk factor categories. Circulation. 1998; 97(18):1837-47. DOI: 10.1161/01.cir.97.18.1837. View

2.
Roberts A, Monzon-Bordonaba F, Van Deerlin P, Holder J, Macones G, Morgan M . Association of polymorphism within the promoter of the tumor necrosis factor alpha gene with increased risk of preterm premature rupture of the fetal membranes. Am J Obstet Gynecol. 1999; 180(5):1297-302. DOI: 10.1016/s0002-9378(99)70632-0. View

3.
Lopez Silva M, Diz-Iglesias P, Seoane-Romero J, Quintas V, Mendez-Brea F, Varela-Centelles P . [Update in family medicine: Periodontal disease]. Semergen. 2016; 43(2):141-148. DOI: 10.1016/j.semerg.2016.02.005. View

4.
Thompson S, Kienast J, Pyke S, Haverkate F, van de Loo J . Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med. 1995; 332(10):635-41. DOI: 10.1056/NEJM199503093321003. View

5.
Skoog T, Dichtl W, Boquist S, Skoglund-Andersson C, Karpe F, Tang R . Plasma tumour necrosis factor-alpha and early carotid atherosclerosis in healthy middle-aged men. Eur Heart J. 2002; 23(5):376-83. DOI: 10.1053/euhj.2001.2805. View